Jane Wasman

Insider Reports History

Location
C/O Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley, NY
Signature
/s/ Jane Wasman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jane Wasman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RIGEL PHARMACEUTICALS INC Director Common Stock 12.5K $238K $19.06 May 23, 2025 Direct
SELLAS Life Sciences Group, Inc. Director Common Stock 30.4K $51.4K $1.69 May 30, 2025 Direct
ATHERSYS, INC / NEW Director Common Stock 35.1K $879 $0.03 Jan 9, 2023 Direct
ATHERSYS, INC / NEW Director Stock Option (right to purchase) 64.1K Sep 16, 2022 Direct
SELLAS Life Sciences Group, Inc. Director Stock Option (Right to Buy) 18.5K Jan 10, 2025 Direct
RIGEL PHARMACEUTICALS INC Director Stock Option (Right to Buy) 3K May 23, 2025 Direct

Insider Reports Filed by Jane Wasman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLS SELLAS Life Sciences Group, Inc. May 30, 2025 1 $33.8K 4 Jun 2, 2025 Director
RIGL RIGEL PHARMACEUTICALS INC May 23, 2025 2 $0 4 May 28, 2025 Director
SLS SELLAS Life Sciences Group, Inc. Jan 10, 2025 2 $0 4 Jan 14, 2025 Director
RIGL RIGEL PHARMACEUTICALS INC May 25, 2024 2 $0 4 May 29, 2024 Director
SLS SELLAS Life Sciences Group, Inc. Jan 22, 2024 2 $0 4 Jan 25, 2024 Director
RIGL RIGEL PHARMACEUTICALS INC May 26, 2023 2 $0 4 Jul 12, 2023 Director
SLS SELLAS Life Sciences Group, Inc. Feb 2, 2023 2 $0 4 Feb 3, 2023 Director
ATHX ATHERSYS, INC / NEW Jan 9, 2023 1 $0 4 Jan 11, 2023 Director
ATHX ATHERSYS, INC / NEW Sep 16, 2022 2 $0 4 Sep 20, 2022 Director
RIGL RIGEL PHARMACEUTICALS INC May 20, 2022 2 $0 4 May 23, 2022 Director
SLS SELLAS Life Sciences Group, Inc. Jan 31, 2022 2 $0 4 Feb 1, 2022 Director
ATHX ATHERSYS, INC / NEW Jun 15, 2021 1 $0 4 Jun 15, 2021 Director
RIGL RIGEL PHARMACEUTICALS INC May 19, 2021 2 $0 4 May 21, 2021 Director